Page last updated: 2024-12-04

alpha,beta-dihydroxyisovaleric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha,beta-dihydroxyisovaleric acid: RN in 9th CI Form Index for (+-)-isomer: 26097-26-7; RN for (R)-isomer: 19451-56-0 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,3-dihydroxy-3-methylbutanoic acid : A dihydroxy monocarboxylic acid that is isovaleric acid which is substituted by hydroxy groups at positions 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID677
CHEBI ID15689
SCHEMBL ID42068
MeSH IDM0089923

Synonyms (28)

Synonym
1756-18-9
nsc-181496
nsc181496
2,3-dihydroxy-3-methylbutyric acid
CHEBI:15689
alpha,beta-dihydroxyisovaleric acid
2,3-dihydroxy-3-methylbutanoic acid
alpha,beta-dihydroxyisovalerate
3-methyl-2,3-dihydroxybutyric acid
(+/-) alpha,beta-dihydroxyisovaleric acid
2,3-dihydroxyisovaleric acid
butyric acid, 2,3-dihydroxy-3-methyl-
butanoic acid, 2,3-dihydroxy-3-methyl
C04039
2,3-dihydroxy-isovaleric acid
AKOS006375430
butanoic acid, 2,3-dihydroxy-3-methyl-
nsc 181496
SCHEMBL42068
JTEYKUFKXGDTEU-UHFFFAOYSA-N
2,3-dihydroxy-3-methyl-butanoic acid
Q27098191
dihydroxy-valerate
DTXSID201292206
BAA75618
EN300-299532
2,3-dihydroxy-3-methylbutanoicacid
Z1205493888
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dihydroxy monocarboxylic acidAny hydroxy monocarboxylic acid carrying at least two hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]